The evolving story of macrophages in acute liver failure

Immunology Letters

Volumn 147, Issue 1-2, 2012, Pages 1-9

  Yang, Qiao ^a   Shi, Yu ^a   He, Jiliang ^b   Chen, Zhi ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Acute liver failure; Kupffer cells; Macrophages

Indexed keywords

CD163 ANTIGEN; FIBRINOGEN; FIBRINOGEN LIKE PROTEIN 2; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LIVER FAILURE; ADAPTIVE IMMUNITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INTERACTION; CYTOKINE RESPONSE; ENDOTHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; KUPFFER CELL; LIVER PROTECTION; LIVER TOXICITY; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PHENOTYPIC PLASTICITY; POLARIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL;

ANIMALS; CELL COMMUNICATION; HUMANS; KUPFFER CELLS; LIVER FAILURE, ACUTE; MACROPHAGES; NATURAL KILLER T-CELLS;

EID: 84865357762     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.07.002     Document Type: Review

References (112)

1. Rolando N., Wade J., Davalos M., Wendon J., Philpott-Howard J., Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000, 32:734-739.
2. Riordan S.M., Williams R. Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 2000, 32:63-76.
3. Acute liver failure 1997, Cambridge University Press, United Kingdom. M.L. William, W. Roger (Eds.).
4. Crispe I.N. The liver as a lymphoid organ. Annu Rev Immunol 2009, 27:147-163.
5. + T cells in T helper 1 immune responses. Immunol Rev 2000, 174:35-46.
6. Dambach D.M., Watson L.M., Gray K.R., Durham S.K., Laskin D.L. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 2002, 35:1093-1103.
7. Toth C.A., Thomas P. Liver endocytosis and Kupffer cells. Hepatology 1992, 16:255-266.
8. Bilzer M., Roggel F., Gerbes A.L. Role of Kupffer cells in host defense and liver disease. Liver Int 2006, 26:1175-1186.
9. Parker G.A., Picut C.A. Liver immunobiology. Toxicol Pathol 2005, 33:52-62.
10. Gordon S. The macrophage: past, present and future. Eur J Immunol 2007, 37:S9-S17.
11. Laskin D.L. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol 2009, 22:1376-1385.
12. Benoit M., Desnues B., Mege J.L. Macrophage polarization in bacterial infections. J Immunol 2008, 181:3733-3739.
13. Montaner L.J., da Silva R.P., Sun J., Sutterwala S., Hollinshead M., Vaux D., et al. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-γ or IL-10. J Immunol 1999, 162:4606-4613.
14. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
15. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
16. Leist M., Gantner F., Naumann H., Bluethmann H., Vogt K., Brigelius-Flohé R., et al. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology 1997, 112:923-934.
17. Gantner F., Leist M., Lohse A.W., Germann P.G., Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995, 21:190-198.
18. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994, 179:1529-1537.
19. Kamata H., Honda S., Maeda S., Chang L., Hirata H., Karin M. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120:649-661.
20. Nakashima H., Kinoshita M., Nakashima M., Habu Y., Shono S., Uchida T., et al. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice. Hepatology 2008, 48:1979-1988.
21. Presti R.M., Pollock J.L., Dal Canto A.J., O'Guin A.K., Virgin H.W. Interferon γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 1998, 188:577-588.
22. Fan X.P., Zou Z.Q., Long B., Guo Y.M., Wang S.K., Jia D.X., et al. Enhanced demethylation of interferon-γ gene promoter in peripheral blood mononuclear cells is associated with acute-on-chronic hepatitis B liver failure. Tohoku J Exp Med 2011, 224:13-19.
23. Küsters S., Gantner F., Künstle G., Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996, 111:462-471.
24. 2, reactive oxygen species, and lipid peroxidation in CNS pathologies. BMB Rep 2008, 41:560-567.
25. Liu P., McGuire G.M., Fisher M.A., Farhood A., Smith C.W., Jaeschke H. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock 1995, 3:56-62.
26. Jaeschke H., Bautista A.P., Spolarics Z., Spitzer J.J. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukoc Biol 1992, 52:377-382.
27. Ferret P.J., Hammoud R., Tulliez M., Tran A., Trébéden H., Jaffray P., et al. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 2001, 33:1173-1180.
28. Andersson U., Tracey K.J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011, 29:139-162.
29. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000, 192:565-570.
30. Dragomir A.C., Laskin J.D., Laskin D.L. Macrophage activation by factors released from acetaminophen-injured hepatocytes: potential role of HMGB1. Toxicol Appl Pharmacol 2011, 253:170-177.
31. Tsung A., Sahai R., Tanaka H., Nakao A., Fink M.P., Lotze M.T., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005, 201:1135-1143.
32. Yadav A., Saini V., Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 2010, 411:1570-1579.
33. Yamaguchi Y., Matsumura F., Takeya M., Ichiguchi O., Kuratsu J.I., Horiuchi T., et al. Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats. Hepatology 1998, 27:727-734.
34. Leifeld L., Dumoulin F.L., Purr I., Janberg K., Trautwein C., Wolff M., et al. Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol 2003, 199:335-344.
35. Antoniades C.G., Quaglia A., Taams L.S., Mitry R.R., Hussain M., Abeles R., et al. Source and characterisation of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology 2012, 56:735-746.
36. Hogaboam C.M., Bone-Larson C.L., Steinhauser M.L., Matsukawa A., Gosling J., Boring L., et al. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. Am J Pathol 2000, 156:1245-1252.
37. McGilvray I.D., Lu Z., Wei A.C., Dackiw A.P., Marshall J.C., Kapus A., et al. Murine hepatitis virus strain 3 induces the macrophage prothrombinase fgl-2 through p38 mitogen-activated protein kinase activation. J Biol Chem 1998, 273:32222-32229.
38. Marsden P.A., Ning Q., Fung L.S., Luo X., Chen Y., Mendicino M., et al. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest 2003, 112:58-66.
39. Ding J.W., Ning Q., Liu M.F., Lai A., Leibowitz J., Peltekian K.M., et al. Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J Virol 1997, 71:9223-9230.
40. Gao S., Wang M., Ye H., Guo J., Xi D., Wang Z., et al. Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther 2010, 21:969-977.
41. Zhu C., Sun Y., Luo X., Yan W., Xi D., Ning Q. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther 2006, 17:589-600.
42. Holt M.P., Cheng L., Ju C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol 2008, 84:1410-1421.
43. Bourdi M., Masubuchi Y., Reilly T.P., Amouzadeh H.R., Martin J.L., George J.W., et al. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 2002, 35:289-298.
44. Louis H., Le Moine O., Peny M.O., Quertinmont E., Fokan D., Goldman M., et al. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 1997, 25:1382-1389.
45. Li J., Wu W., Peng G., Chen F., Bai M., Zheng M., et al. HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunol Cell Biol 2010, 88:834-841.
46. Erhardt A., Biburger M., Papadopoulos T., Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 2007, 45:475-485.
47. Louis H., Le Moine O., Peny M.O., Gulbis B., Nisol F., Goldman M., et al. Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology 1997, 112:935-942.
48. Nagaki M., Tanaka M., Sugiyama A., Ohnishi H., Moriwaki H. Interleukin-10 inhibits hepatic injury and tumor necrosis factor-α and interferon-γ mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice. J Hepatol 1999, 31:815-824.
49. Santucci L., Fiorucci S., Chiorean M., Brunori P.M., Di Matteo F.M., Sidoni A., et al. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology 1996, 111:736-744.
50. Flavell R.A., Sanjabi S., Wrzesinski S.H., Licona-Limón P. The polarization of immune cells in the tumour environment by TGFβ. Nat Rev Immunol 2010, 10:554-567.
51. Wynn T.A., Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010, 30:245-257.
52. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
53. Meulmeester E., Ten Dijke P. The dynamic roles of TGF-β in cancer. J Pathol 2011, 223:205-218.
54. Zhang M., Xu S., Han Y., Cao X. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β. Hepatology 2011, 53:306-316.
55. Nishimoto N. Interleukin-6 as a therapeutic target in candidate inflammatory diseases. Clin Pharmacol Ther 2010, 87:483-487.
56. Izumi S., Hughes R.D., Langley P.G., Pernambuco J.R., Williams R. Extent of the acute phase response in fulminant hepatic failure. Gut 1994, 35:982-986.
57. Masubuchi Y., Bourdi M., Reilly T.P., Graf M.L., George J.W., Pohl L.R. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun 2003, 304:207-212.
58. Kovalovich K., DeAngelis R.A., Li W., Furth E.E., Ciliberto G., Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000, 31:149-159.
59. + T cell- and STAT3-dependent manners. J Immunol 2004, 172:5648-5655.
60. Fabriek B.O., van Bruggen R., Deng D.M., Ligtenberg A.J., Nazmi K., Schornagel K., et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009, 113:887-892.
61. Buechler C., Ritter M., Orsó E., Langmann T., Klucken J., Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro-and antiinflammatory stimuli. J Leukoc Biol 2000, 67:97-103.
62. Hiraoka A., Horiike N., Akbar S.M., Michitaka K., Matsuyama T., Onji M. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol 2005, 40:52-56.
63. Møller H.J., Grønbaek H., Schiødt F.V., Holland-Fischer P., Schilsky M., Munoz S., et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol 2007, 47:671-676.
64. Nakao A., Taki S., Yasui M., Kimura Y., Nonami T., Harada A., et al. The fate of intravenously injected endotoxin in normal rats and in rats with liver failure. Hepatology 1994, 19:1251-1256.
65. Canalese J., Wyke R.J., Vergani D., Eddleston A.L., Williams R. Circulating immune complexes in patients with fulminant hepatic failure. Gut 1981, 22:845-848.
66. Wolk K., Döcke W.D., von Baehr V., Volk H.D., Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000, 96:218-223.
67. Wolk K., Döcke W., von Baehr V., Volk H., Sabat R. Comparison of monocyte functions after LPS- or IL-10-induced reorientation: importance in clinical immunoparalysis. Pathobiology 1999, 67:253-256.
68. Antoniades C.G., Berry P.A., Davies E.T., Hussain M., Bernal W., Vergani D., et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 2006, 44:34-43.
69. Xing T., Li L., Cao H., Huang J. Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clin Exp Immunol 2007, 147:184-188.
70. Antoniades C.G., Berry P.A., Wendon J.A., Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008, 49:845-861.
71. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010, 11:889-896.
72. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483.
73. Porta C., Rimoldi M., Raes G., Brys L., Ghezzi P., Di Liberto D., et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB. Proc Natl Acad Sci USA 2009, 106:14978-14983.
74. Saccani A., Schioppa T., Porta C., Biswas S.K., Nebuloni M., Vago L., et al. p50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 2006, 66:11432-11440.
75. Ruffell D., Mourkioti F., Gambardella A., Kirstetter P., Lopez R.G., Rosenthal N., et al. A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci USA 2009, 106:17475-17480.
76. Satoh T., Takeuchi O., Vandenbon A., Yasuda K., Tanaka Y., Kumagai Y., et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 2010, 11:936-944.
77. H17 responses. Nat Immunol 2011, 12:231-238.
78. Ishii M., Wen H., Corsa C.A., Liu T., Coelho A.L., Allen R.M., et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 2009, 114:3244-3254.
79. Androulidaki A., Iliopoulos D., Arranz A., Doxaki C., Schworer S., Zacharioudaki V., et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009, 31:220-231.
80. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006, 103:12481-12486.
81. Deaciuc I.V., Bagby G.J., Niesman M.R., Skrepnik N., Spitzer J.J. Modulation of hepatic sinusoidal endothelial cell function by Kupffer cells: an example of intercellular communication in the liver. Hepatology 1994, 19:464-470.
82. Mochida S., Ohno A., Arai M., Tamatani T., Miyasaka M., Fujiwara K. Role of adhesion molecules in the development of massive hepatic necrosis in rats. Hepatology 1996, 23:320-328.
83. van Oosten M., van de Bilt E., de Vries H.E., van Berkel T.J., Kuiper J. Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology 1995, 22:1538-1546.
84. Arai M., Mochida S., Ohno A., Ogata I., Fujiwara K. Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis. Gastroenterology 1993, 104:1466-1471.
85. Mochida S., Ohno A., Arai M., Fujiwara K. Role of adhesion between activated macrophages and endothelial cells in the development of two types of massive hepatic necrosis in rats. J Gastroenterol Hepatol 1995, 10:S38-S42.
86. Holt M.P., Yin H., Ju C. Exacerbation of acetaminophen-induced disturbances of liver sinusoidal endothelial cells in the absence of Kupffer cells in mice. Toxicol Lett 2010, 194:34-41.
87. Gregory S.H., Wing E.J. Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol 2002, 72:239-248.
88. Gregory S.H., Cousens L.P., van Rooijen N., Döpp E.A., Carlos T.M., Wing E.J. Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver. J Immunol 2002, 168:308-315.
89. Holub M., Cheng C.W., Mott S., Wintermeyer P., van Rooijen N., Gregory S.H. Neutrophils sequestered in the liver suppress the proinflammatory response of Kupffer cells to systemic bacterial infection. J Immunol 2009, 183:3309-3316.
90. Sakamoto S., Okanoue T., Itoh Y., Nakagawa Y., Nakamura H., Morita A., et al. Involvement of Kupffer cells in the interaction between neutrophils and sinusoidal endothelial cells in rats. Shock 2002, 18:152-157.
91. Hisama N., Yamaguchi Y., Ishiko T., Miyanari N., Ichiguchi O., Goto M., et al. Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology 1996, 24:1193-1198.
92. Shi J., Fujieda H., Kokubo Y., Wake K. Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology 1996, 24:1256-1263.
93. Okumura Y., Ishibashi H., Shirahama M., Kurokawa S., Kudo J., Okubo H., et al. Kupffer cells modulate natural killer cell activity in vitro by producing prostaglandins. Cell Immunol 1987, 107:89-98.
94. Werner-Wasik M., von Muenchhausen W., Nolan J.P., Cohen S.A. Endogeneous interferon α/β produced by murine Kupffer cells augments liver-associated natural killing activity. Cancer Immunol Immunother 1989, 28(2):107-115.
95. Vanderkerken K., Bouwens L., Van Rooijen N., Van den Berg K., Baekeland M., Wisse E. The role of Kupffer cells in the differentiation process of hepatic natural killer cells. Hepatology 1995, 22:283-290.
96. + T cells by bacterial superantigen-primed Kupffer cells. Hepatology 1999, 30:430-436.
97. Hou X., Zhou R., Wei H., Sun R., Tian Z. NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. Hepatology 2009, 49:940-949.
98. Tu Z., Bozorgzadeh A., Pierce R.H., Kurtis J., Crispe I.N., Orloff M.S. TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med 2008, 205:233-244.
99. Cheng C.W., Duwaerts C.C., Rooijen N., Wintermeyer P., Mott S., Gregory S.H. NK cells suppress experimental cholestatic liver injury by an interleukin-6-mediated, Kupffer cell-dependent mechanism. J Hepatol 2011, 54:746-752.
100. Bautista A.P., Mészáros K., Bojta J., Spitzer J.J. Superoxide anion generation in the liver during the early stage of endotoxemia in rats. J Leukoc Biol 1990, 48:123-128.
101. Tiegs G., Hentschel J., Wendel A.A. T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992, 90:196-203.
102. Gantner F., Leist M., Küsters S., Vogt K., Volk H.D., Tiegs G. T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp Cell Res 1996, 229:137-146.
103. Breous E., Somanathan S., Vandenberghe L.H., Wilson J.M. Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver. Hepatology 2009, 50:612-621.
104. + regulatory T cells. Hepatology 2005, 42:193-199.
105. Ju C., Reilly T.P., Bourdi M., Radonovich M.F., Brady J.N., George J.W., et al. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol 2002, 15:1504-1513.
106. Iimuro Y., Yamamoto M., Kohno H., Itakura J., Fujii H., Matsumoto Y. Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats - analysis of mechanisms of lethality in endotoxemia. J Leukoc Biol 1994, 55:723-728.
107. Yamano T., DeCicco L.A., Rikans L.E. Attenuation of cadmium-induced liver injury in senescent male fischer 344 rats: role of Kupffer cells and inflammatory cytokines. Toxicol Appl Pharmacol 2000, 162:68-75.
108. Canbay A., Feldstein A.E., Higuchi H., Werneburg N., Grambihler A., Bronk S.F., et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 2003, 38:1188-1198.
109. Sitia G., Iannacone M., Aiolfi R., Isogawa M., van Rooijen N., Scozzesi C., et al. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog 2011, 7:e1002061.
110. Marra F. Selective inhibition of NF-κB in Kupffer cells: good, but not for everything. Gut 2009, 58:1581-1582.
111. Hoffmann F., Sass G., Zillies J., Zahler S., Tiegs G., Hartkorn A., et al. A novel technique for selective NF-κB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion. Gut 2009, 58:1670-1678.
112. Kotoh K., Kato M., Kohjima M., Nakamuta M., Enjoji M. A new treatment strategy for acute liver failure. World J Hepatol 2010, 2:395-400.